ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Ann Arbor, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near Ann Arbor, MI, USA:

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (Dauntless-1)

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Farmington Hills, Michigan, United States and 10 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Active, not recruiting
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Toledo, Ohio, United States and 34 other locations

contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis -...

Enrolling
Breast Cancer
Diagnostic Test: Dual-Energy Contrast-Enhanced Spectral Mammography (CESM)
American College of Radiology (ACR)

Detroit, Michigan, United States and 10 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Ann Arbor, Michigan, United States and 107 other locations

with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...

Enrolling
Breast Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

Ann Arbor, Michigan, United States and 38 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

Detroit, Michigan, United States and 63 other locations

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

Maumee, Ohio, United States and 52 other locations

This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...

Enrolling
Estrogen-receptor-positive Breast Cancer
Breast Neoplasms
Drug: goserelin
Drug: (Z)-endoxifen

Phase 2

Atossa Therapeutics

Detroit, Michigan, United States and 14 other locations

in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to r...

Enrolling
HER2-negative Breast Cancer Patients With Brain Metastases
Drug: Utidelone in combination with capecitabine
Drug: Utidelone

Phase 2

Biostar Pharma

Farmington Hills, Michigan, United States and 16 other locations

mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...

Active, not recruiting
Breast Cancer
Drug: Fulvestrant

Phase 3

AstraZeneca
AstraZeneca

Detroit, Michigan, United States and 105 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems